Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(15/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(15/week)
News
United States
(534/week)
Manufacturing
(381/week)
Energy
(301/week)
Technology
(425/week)
Other Manufacturing
(319/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Binimetinib
Aug 10, 2018
Array BioPharma Names Carrie S. Cox Chairman of its Board of Directors
Aug 07, 2018
Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2018 on August 14, 2018
Jul 30, 2018
CStone's MEK Inhibitor CS3006 Receives IND Approval in China
Jul 27, 2018
BRAFTOVI(TM) (encorafenib) + MEKTOVI® (binimetinib) Receives Positive CHMP Opinion for Advanced BRAF-mutant Melanoma
Jul 13, 2018
The National Comprehensive Cancer Network (NCCN) Guidelines Recommend BRAFTOVI(TM) (encorafenib) in Combination with MEKTOVI® (binimetinib) as a Category 1 Treatment Option for Patients with Advanced BRAF-mutant Melanoma
Jun 28, 2018
Avella Selected by Array BioPharma Inc. to distribute BRAFTOVI(TM) (encorafenib) and MEKTOVI® (binimetinib)
Jun 23, 2018
Array BioPharma Announces a 62% Observed Overall Survival at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO 20th World Congress on Gastrointestinal Cancer
Jun 20, 2018
Biotech Resurgent Growth Championed by Cancer Research and Clinical Trial Advancements
Jun 18, 2018
Array BioPharma to Present Overall Survival Results from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant Colorectal Cancer at the ESMO 20th World Congress on Gastrointestinal Cancer
Jun 04, 2018
Array BioPharma Announces Additional Median Overall Survival Results of Encorafenib and Binimetinib in Patients with BRAF-mutant Advanced Melanoma
May 30, 2018
Array BioPharma To Present at the Jefferies 2018 Global Healthcare Conference
May 16, 2018
Array BioPharma Announces Oral Presentation from the Pivotal Phase 3 COLUMBUS trial of the Combination of Encorafenib and Binimetinib in Patients with BRAF-mutant Melanoma at 2018 ASCO Annual Meeting
May 09, 2018
Array Biopharma To Present At The Bank Of America Merrill Lynch 2018 Health Care Conference
Apr 30, 2018
Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2018 On May 9, 2018
Mar 22, 2018
Array BioPharma Announces Publication of Detailed Phase 3 COLUMBUS Trial Data of Encorafenib and Binimetinib in Melanoma Patients in The Lancet Oncology
Mar 05, 2018
Array BioPharma To Present At The Cowen 38th Annual Healthcare Conference
Feb 06, 2018
Array BioPharma Reports Financial Results For The Second Quarter of Fiscal 2018
Jan 30, 2018
Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2018 On February 6, 2018
Jan 20, 2018
Combination of Encorafenib, Binimetinib and Cetuximab Demonstrated an 8 Month Median Progression-Free Survival in BRAF-Mutant Colorectal Cancer in Updated Safety Lead-In Results from BEACON Phase 3 Trial
Nov 30, 2017
ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm
‹‹
Page 2
››
Latest News
May 1, 2024
SkyWater and Lumotive Announce Qualification and Production Start for World’s First Commercially Available...
May 1, 2024
ProPetro Reports Financial Results for the First Quarter of 2024
May 1, 2024
Gold H2 Appoints Prabhdeep Singh Sekhon as CEO
May 1, 2024
Donaldson to Webcast Third Quarter Fiscal 2024 Earnings Conference Call
May 1, 2024
EVgo Expansion in Los Angeles Recognized with 1st Place Leadership Award by Largest Municipal Utility in the...
May 1, 2024
Orgill Launches B2B2C eCommerce Powered by Elastic Path
May 1, 2024
Trinity Industries, Inc. Announces First Quarter 2024 Results
May 1, 2024
Silgan Announces First Quarter 2024 Results
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events